Search Results 431-440 of 17562 for metformin

1. Endocrinology - Clinical trials

   [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

2. Tranylcypromine (oral route) - Side effects & dosage - Mayo Clinic

   Metformin; Nateglinide; Repaglinide; Tolazamide; Tolbutamide. Other Interactions. Certain medicines should not be used at or around the time of eating food or ...

3. Iohexol (injection route, intrathecal route, intravenous route) - Side effects & uses - Mayo Clinic

   Metformin; Metipranolol; Metoprolol; Nadolol; Nebivolol; Oxprenolol; Penbutolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol. Other Interactions. Certain ...

4. Ioversol (injection route) - Side effects & uses - Mayo Clinic

   If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Metformin. Other Interactions.

5. Study of Critical Outcomes in Pregnant Patients on Insulin Pump with Type 1 Diabetes - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

6. Olmesartan and hydrochlorothiazide (oral route) - Mayo Clinic

   This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. Lowering blood pressure can reduce ...

7. Gestational diabetes - Doctors and departments - Mayo Clinic

   This high blood sugar disorder develops during pregnancy and can affect your pregnancy and your baby's health. Read about risks, prevention and treatment.

8. Diabetes and depression: Coping with the two conditions - Mayo Clinic

   Psychotherapy. Similarly, people who participate in psychotherapy, especially cognitive behavioral therapy, can improve their depression. This can help them ...

9. Data-Driven Behavioral-Change Interventions to Improve Type 1 Diabetes (TID) Treatment Adherence - Mayo Clinic

   About this study. The purpose of this study is to assess a novel informatics approach that incorporates the use of patient's diabetes self-care data into ...

10. A Study of The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension)

    Concurrent use of any non-insulin glucose-lowering agent other than metformin (including GLP-1 agonists, Symlin, DPP-4 inhibitors, SGLT-2 inhibitors, ...